New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsComparePT-141 (Bremelanotide) vs Glutathione

PT-141 (Bremelanotide) vs Glutathione

Side-by-side comparison of key properties, dosing, and research.

Sexual Health & Libido
PT-141 (Bremelanotide)
Anti-Aging & LongevityImmune Support
Glutathione
Summary
PT-141 (Bremelanotide) is a cyclic peptide melanocortin receptor agonist that enhances sexual desire and arousal through central nervous system mechanisms. It is FDA-approved as Vyleesi for premenopausal women with hypoactive sexual desire disorder (HSDD).
Glutathione is the body's master endogenous antioxidant tripeptide, composed of glutamate, cysteine, and glycine. It neutralizes reactive oxygen species, supports detoxification in the liver, recycles other antioxidants (vitamins C and E), and plays a central role in immune function, DNA repair, and cellular redox balance.
Half-Life
2–3 hours
Minutes to hours depending on route; IV half-life approximately 10-30 minutes
Admin Route
SubQ
Oral (liposomal preferred), Sublingual, Intravenous, Nebulized/inhaled, Topical
Research
Typical Dose
0.5–1.75 mg
250-1000 mg per day
Frequency
As needed (not daily)
Once or twice daily
Key Benefits
  • Enhances sexual desire and libido in both men and women
  • Improves arousal through central nervous system activation
  • Effective for psychological erectile dysfunction
  • Works for female sexual arousal disorder
  • May improve sexual satisfaction and intensity
  • Fast-acting — effects within 45–60 minutes
  • FDA-approved for HSDD in premenopausal women
  • Primary endogenous antioxidant and free radical scavenger
  • Supports hepatic detoxification of xenobiotics and heavy metals
  • Recycles vitamins C and E to maintain antioxidant network
  • Modulates immune function and T-cell activity
  • Skin brightening via inhibition of tyrosinase (IV/topical routes)
  • Neuroprotective in oxidative stress-related conditions
  • Mitochondrial protection and energy metabolism support
Side Effects
  • Nausea (most common — 40% of users in clinical trials)
  • Facial flushing and warmth
  • Transient blood pressure changes (typically increase then normalize)
  • Headache
  • +2 more
  • Oral bioavailability is limited (largely hydrolyzed in gut); liposomal or sublingual forms preferred
  • IV administration: rare allergic reactions, vein irritation
  • High-dose supplementation may cause zinc depletion over time
  • Inhaled glutathione may trigger bronchoconstriction in asthmatics
Stacks With